Can you sum up what your company does in six? Not six minutes. Six words. That was a challenge set to attendees at One Nucleus’s Boston Bootcamp in the US in April. It was discussed at One Nucleus’s On Helix event in Cambridge a couple of weeks ago, and it really grabbed me. It grabbed […]
ReBio Pharma appointed leading ocular oncologist Professor Mandeep Sagoo as Chief Medical Officer ReBio Pharma, a biotechnology company developing novel, targeted, eye- and vision-preserving therapies for ocular oncology, announced the appointment of Professor Mandeep Sagoo, MB, PhD, FRCS (Ed), FRCOphth, as Chief Medical Officer (CMO). In this role, Professor Sagoo will lead ReBio’s clinical and […]
Mission Therapeutics strikes deal worth up to $292 million for Dimerix Ltd to develop Acute Kidney Injury asset MTX652, sharpens focus on its CNS pipeline Cambridge (UK) based Mission Therapeutics, a clinical-stage biotechnology company developing novel therapeutics that promote the removal of dysfunctional mitochondria to restore cellular health and function, announced the divestment of MTX652, […]
SOMETHING momentous happened in the world of media earlier this month.Social media and video platforms overtook “traditional” news organisations as the most popular source of news. The results are from a highly-respected global annual survey about how news is sourced and consumed, by the Reuters Institute and Oxford University. I actually first heard about this […]
Sofinnova Partners announced Myricx Bio agrees to be acquired by Novartis Sofinnova Partners, a leading European life sciences venture capital firm, announced that its portfolio company Myricx Bio has reached an agreement to be acquired by Novartis for up to $1.5 billion, including $1.1 billion cash upfront plus potential milestone payments. Sofinnova Partners seeded the […]
